Beacon Pointe Advisors, LLC Johnson & Johnson Transaction History

Beacon Pointe Advisors, LLC

  • $11.3 Billion
  • Q3 2025

A detailed history of Beacon Pointe Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 267,129 shares of JNJ stock, worth $53.3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
267,129
Previous 287,202 6.99%
Holding current value
$53.3 Million
Previous $43.9 Million 12.9%
% of portfolio
0.44%
Previous 0.47%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$155.17 - $185.42 $3.11 Million - $3.72 Million
-20,073 Reduced 6.99%
267,129 $49.5 Million
Q2 2025

Aug 13, 2025
SELL
$146.36 - $159.82 $4.33 Million - $4.73 Million
-29,611 Reduced 9.35%
287,202 $43.9 Million
Q1 2025

May 13, 2025
BUY
$142.06 - $167.7 $6.77 Million - $7.99 Million
47,636 Added 17.7%
316,813 $52.5 Million
Q4 2024

Feb 14, 2025
SELL
$143.34 - $165.86 $1.7 Million - $1.97 Million
-11,849 Reduced 4.22%
269,177 $38.9 Million
Q3 2024

Nov 14, 2024
SELL
$145.48 - $167.38 $1.89 Million - $2.17 Million
-12,979 Reduced 4.41%
281,026 $45.5 Million
Q2 2024

Aug 12, 2024
SELL
$144.38 - $157.78 $6.2 Million - $6.78 Million
-42,951 Reduced 12.75%
294,005 $43 Million
Q1 2024

May 14, 2024
SELL
$155.22 - $162.74 $2.8 Million - $2.94 Million
-18,064 Reduced 5.09%
336,956 $53.3 Million
Q4 2023

Feb 08, 2024
SELL
$145.6 - $158.88 $1.62 Million - $1.77 Million
-11,141 Reduced 3.04%
355,020 $55.6 Million
Q3 2023

Nov 14, 2023
BUY
$155.75 - $174.48 $15.3 Million - $17.1 Million
98,198 Added 36.65%
366,161 $57 Million
Q2 2023

Aug 11, 2023
SELL
$154.35 - $166.11 $3.64 Million - $3.92 Million
-23,600 Reduced 8.09%
267,963 $44.4 Million
Q1 2023

May 12, 2023
BUY
$151.05 - $180.26 $2.82 Million - $3.36 Million
18,652 Added 6.83%
291,563 $45.2 Million
Q4 2022

Feb 14, 2023
BUY
$160.2 - $179.79 $269,456 - $302,406
1,682 Added 0.62%
272,911 $48.2 Million
Q3 2022

Nov 09, 2022
SELL
$161.33 - $179.52 $1.39 Million - $1.55 Million
-8,643 Reduced 3.09%
271,229 $44.3 Million
Q2 2022

Aug 11, 2022
SELL
$168.19 - $186.01 $16.1 Million - $17.8 Million
-95,859 Reduced 25.51%
279,872 $49.7 Million
Q1 2022

May 17, 2022
BUY
$158.14 - $179.59 $39 Million - $44.3 Million
246,399 Added 190.52%
375,731 $66.6 Million
Q4 2021

Feb 14, 2022
SELL
$155.93 - $173.01 $10.5 Million - $11.7 Million
-67,341 Reduced 34.24%
129,332 $22.1 Million
Q3 2021

Nov 15, 2021
BUY
$161.5 - $179.47 $18.2 Million - $20.2 Million
112,405 Added 133.39%
196,673 $31.8 Million
Q2 2021

Aug 17, 2021
BUY
$159.48 - $171.07 $7.7 Million - $8.26 Million
48,275 Added 134.12%
84,268 $13.9 Million
Q1 2021

May 18, 2021
SELL
$153.07 - $170.48 $125,976 - $140,305
-823 Reduced 2.24%
35,993 $5.91 Million
Q4 2020

Feb 12, 2021
BUY
$137.11 - $157.38 $1.17 Million - $1.34 Million
8,503 Added 30.03%
36,816 $5.79 Million
Q3 2020

Nov 16, 2020
SELL
$140.38 - $153.83 $337,052 - $369,345
-2,401 Reduced 7.82%
28,313 $4.22 Million
Q2 2020

Aug 14, 2020
BUY
$128.81 - $155.51 $607,983 - $734,007
4,720 Added 18.16%
30,714 $4.31 Million
Q1 2020

May 15, 2020
BUY
$111.14 - $153.99 $2.11 Million - $2.92 Million
18,985 Added 270.87%
25,994 $3.41 Million
Q4 2019

Feb 14, 2020
BUY
$127.5 - $146.44 $387,855 - $445,470
3,042 Added 76.68%
7,009 $1.02 Million
Q3 2019

Nov 14, 2019
SELL
$126.95 - $142.14 $269,260 - $301,478
-2,121 Reduced 34.84%
3,967 $514,000
Q2 2019

Aug 14, 2019
BUY
$131.15 - $144.24 $79,083 - $86,976
603 Added 10.99%
6,088 $849,000
Q1 2019

May 14, 2019
SELL
$125.72 - $139.79 $15,840 - $17,613
-126 Reduced 2.25%
5,485 $765,000
Q4 2018

Feb 01, 2019
BUY
$122.84 - $147.84 $689,255 - $829,530
5,611 New
5,611 $724,000

Others Institutions Holding JNJ

# of Institutions
4,829
Shares Held
1.74B
Call Options Held
19.8M
Put Options Held
16.8M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email